Module

Understanding Mechanisms of Drug Action and Viral Resistance in HBV

Source: Hepatitis Annual Update 2005

Understanding Mechanisms of Drug Action and Viral Resistance in HBV


CME Program Director: Patrick J. Lynch, MD

Faculty:

  • T. Jake Liang, MD

CME CREDIT INFORMATION

Release Date: 11/04/05

Expiration Date: 11/03/06


Physicians: maximum of 1 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the mechanisms of HBV replication.

  • Review issues of integration, latency, and drug resistance, and describe the assays used for measuring HBV, including DNA and genotype assays.

  • Define molecular targets for antiviral therapy and mechanisms of viral resistance.


Content includes:

  • HBV Replication: Overview
  • Molecular Targets of HBV Treatment
  • Molecular Basis for Drug Resistance
  • Monitoring Drug Resistance
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.